NCT03659864View on ClinicalTrials.gov

The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

March 29, 2019

Study Completion Date

November 27, 2020

Conditions
Blood BiomarkersVasodilationBlood ClottingLung FunctionHealthy Volunteers
Interventions
OTHER

diesel exhaust particulate

aerosolised diesel exhaust particulate

OTHER

carbon nanoparticles

aerosolised 'clean' carbon nanoparticles

OTHER

small graphene oxide

aerosolised 'small' graphene oxide

OTHER

ultrasmall graphene oxide

aerosolised 'ultrasmall' graphene oxide

OTHER

filtered air

control: filtered air

Trial Locations (1)

EH16 4SB

Centre for Cardiovascular Science, Edinburgh

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

lead

University of Edinburgh

OTHER

NCT03659864 - The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles | Biotech Hunter | Biotech Hunter